Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Imuvert can prevent some chemotherapy-induced hair loss.

Adding a second method to PROTACs could improve cancer treatment.

Rituximab may cause skin issues, but baricitinib can help improve them.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.